Data as of Oct 21
| +0.11 / +4.01%|
The 5 analysts offering 12-month price forecasts for Synergy Pharmaceuticals Inc have a median target of 9.00, with a high estimate of 20.00 and a low estimate of 8.38. The median estimate represents a +215.79% increase from the last price of 2.85.
The current consensus among 5 polled investment analysts is to Buy stock in Synergy Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.